95 related articles for article (PubMed ID: 15848273)
1. Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the hemagglutinin of influenza virus.
Yamamoto N; Urade M
Microbes Infect; 2005 Apr; 7(4):674-81. PubMed ID: 15848273
[TBL] [Abstract][Full Text] [Related]
2. Pathogenic significance of alpha-N-acetylgalactosaminidase activity found in the envelope glycoprotein gp160 of human immunodeficiency virus Type 1.
Yamamoto N
AIDS Res Hum Retroviruses; 2006 Mar; 22(3):262-71. PubMed ID: 16545013
[TBL] [Abstract][Full Text] [Related]
3. Immunotherapy of metastatic breast cancer patients with vitamin D-binding protein-derived macrophage activating factor (GcMAF).
Yamamoto N; Suyama H; Yamamoto N; Ushijima N
Int J Cancer; 2008 Jan; 122(2):461-7. PubMed ID: 17935130
[TBL] [Abstract][Full Text] [Related]
4. Immunotherapy of HIV-infected patients with Gc protein-derived macrophage activating factor (GcMAF).
Yamamoto N; Ushijima N; Koga Y
J Med Virol; 2009 Jan; 81(1):16-26. PubMed ID: 19031451
[TBL] [Abstract][Full Text] [Related]
5. Prognostic utility of serum alpha-N-acetylgalactosaminidase and immunosuppression resulted from deglycosylation of serum Gc protein in oral cancer patients.
Yamamoto N; Naraparaju VR; Urade M
Cancer Res; 1997 Jan; 57(2):295-9. PubMed ID: 9000571
[TBL] [Abstract][Full Text] [Related]
6. Immunotherapy of metastatic colorectal cancer with vitamin D-binding protein-derived macrophage-activating factor, GcMAF.
Yamamoto N; Suyama H; Nakazato H; Yamamoto N; Koga Y
Cancer Immunol Immunother; 2008 Jul; 57(7):1007-16. PubMed ID: 18058096
[TBL] [Abstract][Full Text] [Related]
7. The Effect of Fucoidan from the Brown Alga
Bakunina I; Chadova O; Malyarenko O; Ermakova S
Mar Drugs; 2018 May; 16(5):. PubMed ID: 29748462
[TBL] [Abstract][Full Text] [Related]
8. Serum alpha-N-acetylgalactosaminidase is associated with diagnosis/prognosis of patients with squamous cell carcinoma of the uterine cervix.
Reddi AL; Sankaranarayanan K; Arulraj HS; Devaraj N; Devaraj H
Cancer Lett; 2000 Sep; 158(1):61-4. PubMed ID: 10940510
[TBL] [Abstract][Full Text] [Related]
9. Immunotherapy of BALB/c mice bearing Ehrlich ascites tumor with vitamin D-binding protein-derived macrophage activating factor.
Yamamoto N; Naraparaju VR
Cancer Res; 1997 Jun; 57(11):2187-92. PubMed ID: 9187119
[TBL] [Abstract][Full Text] [Related]
10. Structural modification of serum vitamin D3-binding protein and immunosuppression in AIDS patients.
Yamamoto N; Naraparaju VR; Srinivasula SM
AIDS Res Hum Retroviruses; 1995 Nov; 11(11):1373-8. PubMed ID: 8573395
[TBL] [Abstract][Full Text] [Related]
11. Tumor cell alpha-N-acetylgalactosaminidase activity and its involvement in GcMAF-related macrophage activation.
Mohamad SB; Nagasawa H; Uto Y; Hori H
Comp Biochem Physiol A Mol Integr Physiol; 2002 May; 132(1):1-8. PubMed ID: 12062184
[TBL] [Abstract][Full Text] [Related]
12. Immunotherapy for Prostate Cancer with Gc Protein-Derived Macrophage-Activating Factor, GcMAF.
Yamamoto N; Suyama H; Yamamoto N
Transl Oncol; 2008 Jul; 1(2):65-72. PubMed ID: 18633461
[TBL] [Abstract][Full Text] [Related]
13. Alteration of α-N-acetylgalactosaminidase (nagalase) concentration in alcohol-dependent individuals without liver disease, during the detoxification therapy.
Zoga M; Nikou T; Ioannidis A; Tzavellas E; Paparrigopoulos T; Lambrokostopoulos KT; Vasdekis VG; Magana M; Chatzipanagiotou S
Drug Alcohol Depend; 2017 Jan; 170():147-151. PubMed ID: 27907862
[TBL] [Abstract][Full Text] [Related]
14. Deglycosylation of serum vitamin D3-binding protein by alpha-N-acetylgalactosaminidase detected in the plasma of patients with systemic lupus erythematosus.
Yamamoto N; Naraparaju VR; Moore M; Brent LH
Clin Immunol Immunopathol; 1997 Mar; 82(3):290-8. PubMed ID: 9073553
[TBL] [Abstract][Full Text] [Related]
15. Deglycosylation of serum vitamin D3-binding protein leads to immunosuppression in cancer patients.
Yamamoto N; Naraparaju VR; Asbell SO
Cancer Res; 1996 Jun; 56(12):2827-31. PubMed ID: 8665521
[TBL] [Abstract][Full Text] [Related]
16. Effect of salivary gland adenocarcinoma cell-derived alpha-N-acetylgalactosaminidase on the bioactivity of macrophage activating factor.
Matsuura T; Uematsu T; Yamaoka M; Furusawa K
Int J Oncol; 2004 Mar; 24(3):521-8. PubMed ID: 14767536
[TBL] [Abstract][Full Text] [Related]
17. Antitumor effect of vitamin D-binding protein-derived macrophage activating factor on Ehrlich ascites tumor-bearing mice.
Koga Y; Naraparaju VR; Yamamoto N
Proc Soc Exp Biol Med; 1999 Jan; 220(1):20-6. PubMed ID: 9893164
[TBL] [Abstract][Full Text] [Related]
18. Is α-N-acetylgalactosaminidase the key to curing cancer? A mini-review and hypothesis.
Saburi E; Tavakol-Afshari J; Biglari S; Mortazavi Y
J BUON; 2017; 22(6):1372-1377. PubMed ID: 29332325
[TBL] [Abstract][Full Text] [Related]
19. Acylation-mediated membrane anchoring of avian influenza virus hemagglutinin is essential for fusion pore formation and virus infectivity.
Wagner R; Herwig A; Azzouz N; Klenk HD
J Virol; 2005 May; 79(10):6449-58. PubMed ID: 15858028
[TBL] [Abstract][Full Text] [Related]
20. Retroviral display of functional binding domains fused to the amino terminus of influenza hemagglutinin.
Hatziioannou T; Delahaye E; Martin F; Russell SJ; Cosset FL
Hum Gene Ther; 1999 Jun; 10(9):1533-44. PubMed ID: 10395378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
